Funding

Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology. It raises $14Mn in Series A by Andera Partners and Canaan to advance small…

Passage is developing gene therapies for CNS-targeted rare diseases. It launches with $115.5 Mn in series A funding aimed at treating rare monogenic central nervous system (CNS)…

Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in…

Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. It raised $68.5Mn in Series A Financing from Investors that…

Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell (HSC) therapies for the treatment of hematological malignancies. It received $42Mn in…

Indalo Therapeutics was formed by a merger of Antegrin Therapeutics and Cascadia Therapeutics to develop therapies for fibrosis related diseases. It raised $9 million of a $26…

Cabaletta Bio Inc., a biotechnology company focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases. It raised $50Mn in Series B…

Voyager Therapeutics is a clinical stage gene therapy company developing life-changing treatments for Parkinsons disease, a monogenic form of amyotrophic lateral sclerosis (ALS),…

Dewpoint Therapeutics, Inc is a company translating the emerging area of biomolecular condensates into drug discovery. The company was launched by Polaris ventures capital firm,…

Immunochina is a clinical stage biotechnology company, engages in the research and development of chimeric antigen receptor (CAR) T-cell (CAR-T) therapies and a lentiviral vector…